Compare WVE & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | CARG |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.3B |
| IPO Year | 2015 | 2017 |
| Metric | WVE | CARG |
|---|---|---|
| Price | $13.40 | $33.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | $29.94 | ★ $40.91 |
| AVG Volume (30 Days) | ★ 4.0M | 749.8K |
| Earning Date | 03-03-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | $109,230,000.00 | ★ $926,425,000.00 |
| Revenue This Year | N/A | $6.83 |
| Revenue Next Year | $16.20 | $6.12 |
| P/E Ratio | ★ N/A | $23.38 |
| Revenue Growth | ★ 103.75 | 4.21 |
| 52 Week Low | $5.28 | $24.65 |
| 52 Week High | $21.73 | $41.33 |
| Indicator | WVE | CARG |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 31.82 |
| Support Level | $13.22 | $33.25 |
| Resistance Level | $14.51 | $35.05 |
| Average True Range (ATR) | 1.33 | 1.22 |
| MACD | -0.38 | -0.51 |
| Stochastic Oscillator | 3.18 | 10.21 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.